Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins

Clinical and Experimental Ophthalmology

Volumn 39, Issue 3, 2011, Pages 279-281

  Nucci, Carlo ^a   Martucci, Alessio ^a   Martorana, Alessandro ^b   Sancesario, Giulia Maria ^c   Cerulli, Luciano ^a  

^a Departments of Ophthalmology   (Italy)

^b Departments of Neuroscience   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; TIMOLOL; TRAVOPROST;

AGED; ALZHEIMER DISEASE; CASE REPORT; CEREBROSPINAL FLUID LEVEL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; GLAUCOMA; HUMAN; LETTER; MALE; VISUAL FIELD DEFECT;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; DISEASE PROGRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; PEPTIDE FRAGMENTS; TAU PROTEINS; VISUAL FIELDS;

EID: 79954539897     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02452.x     Document Type: Letter

References (6)

1. Wostyn P, Audenaert K, De Deyn PP. Alzheimer's disease and glaucoma: is there a casual relationship? Br J Ophthalmol 2009; 93: 1557-9.
2. Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009; 416: 916-22.
3. Tamura H, Kawakami H, Kanamoto T etal. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. Neurol Sci 2006; 246: 79-83.
4. Bayer AU, Ferrari F. Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye 2002; 16: 209-12.
5. Guo L, Salt TE, Luong V etal. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 2007; 104: 13444-9.
6. Killer HE, Jaggi GP, Flammer J, Miller NR. Is open-angle glaucoma caused by impaired cerebrospinal fluid circulation: around the optic nerve? Clin Experiment Ophthalmol 2008; 36: 308-11.